Clinical Pharmacokinetics

, Volume 3, Issue 1, pp 72–91 | Cite as

Clinical Pharmacokinetics of Diazepam

  • Marinella Mandelli
  • Gianni Tognoni
  • Silvio Garattini


Diazepam is still one of the most used of the benzodiazepine group of drugs. Extensive studies over 10 years have defined a fairly complete profile of its kinetics. Minor aspects relating to patterns of its metabolism and excretion in certain age groups and in some disease states remain to be described quantitatively. However, there is more than sufficient kinetic information available for the requirements of good clinical practice.

For optimum clinical benefit with minimum side-effects the following kinetic properties should be borne in mind: (a) there is a large interindividual variation (up to 30-fold) in dose/blood level ratios, especially when treatment is short-term; (b) the elimination half-life is prolonged in the elderly and the newborn and in some cases of liver disease; (c) there is accumulation of the active N-desmethylated metabolite during long-term treatment; and (d) administration of diazepam to pregnant women leads to rapid distribution from the maternal to fetal compartment: accumulation of both diazepam and desmethyldiazepam could cause prolonged sedation in the newborn. As there does not appear to be any clear relationship between the concentration of diazepam in the plasma and clinical effect, measurement of blood levels, other than for research purposes, is unnecessary.

Based on kinetic data, a single administration of diazepam at night should be adequate for hypnotic and anxiolytic effects in most patients.


Diazepam Clinical Pharmacology Clinical Pharmacokinetic Oxazepam Enterohepatic Circulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aarskog, D.; Association between maternal intake of diazepam and oral clefts. Lancet 2: 921 (1975).PubMedCrossRefGoogle Scholar
  2. Ackermann, E. and Richter, K.: Diazepam metabolism in human foetal and adult liver. European Journal of Clinical Pharmacology 11: 43–49 (1977).PubMedCrossRefGoogle Scholar
  3. Adoni, A.; Kapitulnik, J.; Kaufmann, N.A.; Ron, M. and Bonheim, S.A.: Effect of maternal administration of diazepam on the bilirubin binding of cord blood serum. American Journal of Obstetrics and Gynecology 115: 557–579 (1973).Google Scholar
  4. Andre, M.; Sibout, M.; Petty, J.-M. and Vert P.: Depression respiratoire et neurologique chez le premature nouveau-ne de mere traetee par diazepam. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 2: 357–366 (1973).PubMedGoogle Scholar
  5. Andreassen, F.: The effects of dialysis on the protein binding of drugs in patients with acute renal failure. Acta Pharmacologica et Toxicologica 34: 284–294 (1974).CrossRefGoogle Scholar
  6. Andreasen, P.B.; Hendel, J.; Greisen, G. and Hvidberg, E.F.: Pharmacokinetics of diazepam in disordered liver function. European Journal of Clinical Pharmacology 10: 115–120 (1976).PubMedCrossRefGoogle Scholar
  7. Arnold, E.: A simple method for determining diazepam and its major metabolites in biological fluids: Application in bioavailability studies. Acta Pharmacologica et Toxicologica 36: 335–352 (1975).PubMedCrossRefGoogle Scholar
  8. Baird, E.S. and Hailey, D.M.: Delayed recovery from a sedative: Correlation of the plasma levels of diazepam with clinical effects after oral and intravenous administration. British Journal of Anaesthesiology 44: 803–808 (1972).CrossRefGoogle Scholar
  9. Belvedere, G.; Tognoni, G.; Frigerio, A. and Morselli, P.L.: A specific, rapid and sensitive method for gas-chromatographic determination of methyl-oxazepam in small samples of blood. Analytical Letters 5: 531–541 (1972).CrossRefGoogle Scholar
  10. Berlin, A.B.; Siwers, B.; Agurell, S.; Hiort, A.; Sjoqvist, F. and Strom, S.: Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clinical Pharmacology and Therapeutics 13: 733–744 (1972).PubMedGoogle Scholar
  11. Bertagni, P.; Bianchi, R.; Marcucci, F.; Mussini, E. and Garattini, S: the enterohepatic circulation of oxazepam-O-glucuronide in guinea pigs. Journal of Pharmacy and Pharmacology. In press (1977).Google Scholar
  12. Bertagni, P.; Marcucci, F.; Mussini, E. and Garattini, S.: Biliary excretion of conjugated hydroxyl benzodiazepines after administration of several benzodiazepines to rats, guinea pigs, and mice. Journal of Pharmaceutical Sciences 61: 965–966 (1972).PubMedCrossRefGoogle Scholar
  13. Blaschke, T.F.: Protein binding and kinetics of drugs in liver diseases. Clinical Pharmacokinetics 2: 32–44 (1977).PubMedCrossRefGoogle Scholar
  14. Bond, A.J.; Hailey, D.M. and Lader, M.H.: Plasma concentrations of benzodiazepines. British Journal of Clinical Pharmacology 4: 51–56 (1977).PubMedCrossRefGoogle Scholar
  15. Booker, H.E. and Celesia, G.G.: Serum concentrations of diazepam in subjects with epilepsy. Archives of Neurology 29: 191–194 (1973).PubMedCrossRefGoogle Scholar
  16. Boston Collaborative Drug Surveillance Program: Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. New England Journal of Medicine 288: 277–280 (1973).CrossRefGoogle Scholar
  17. Brandt, R.: Passage of diazepam and desmethyldiazepam into breast milk. Arzneimittel-Forschung 26: 454–457 (1976).PubMedGoogle Scholar
  18. Cole, A.P. and Hailey, D.M.: Diazepam and active metabolite in breast milk and their transfer to the neonate. Archives in Disease in Childhood 50: 741–742 (1975).CrossRefGoogle Scholar
  19. Costa, E. and Greengard, P. (eds): Mechanism of Action of Benzodiazepines (Raven Press, New York 1975).Google Scholar
  20. Cree, J.E.; Meyer, J. and Hailey, D.M.; Diazepam in labour: Its metabolism and effect on the clinical condition and thermogenesis of the newborn. British Medical Journal 4: 251–255 (1973).PubMedCrossRefGoogle Scholar
  21. Curry, S.H.: Concentration-effect relationships with major and minor tranquilizers. Clinical Pharmacology and Therapeutics 16: 192–197 (1974).PubMedGoogle Scholar
  22. Dasberg, H.: Oral diazepam in hospitalized anxiety patients (With observations on concentration-effect-relationships). Pharmakopsychiatrie Neuro Psychopharmakologie 8: 161–170 (1975).Google Scholar
  23. Dasberg, H.H.; Van der Kleijn, E.; Guelen, P.J.R. and Van Praag, H.M.: Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clinical Pharmacology and Therapeutics 15: 473–483 (1974).PubMedGoogle Scholar
  24. De Silva, J.A.; Koechlin, B.A. and Bader, G.: Blood level distribution patterns of diazepam and its major metabolite in man. Journal of Pharmaceutical Sciences 55: 692–702 (1966).PubMedCrossRefGoogle Scholar
  25. Erkkola, R. and Kanto, J.: Diazepam and Breast-feeding. Lancet 1: 1235–1236 (1972).PubMedCrossRefGoogle Scholar
  26. Erkkola, R.; Kangas, L. and Pekkarinen, A.: The transfer of diazepam across the placenta during labour. Acta Obstetricia et Gynecologica Scandinavica 52: 167–170 (1973).PubMedCrossRefGoogle Scholar
  27. Fuccella, L.M.; Bolcioni, G.; Tamassia, V.; Ferrario, L. and Tognoni, G.: Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. British Journal of Clinical Pharmacology. In press (1977).Google Scholar
  28. Gamble, J.A.S.; Dundee, J.W. and Assaf, R.A.E.: Plasma diazepam levels after single dose oral and intramuscular administration. Anaesthesia 30: 164–169 (1975).PubMedCrossRefGoogle Scholar
  29. Gamble, J.A.S.; Mackay, J.S. and Dundee, J.W.: Plasma levels of diazepam. British Journal of Anesthesiology 45: 1085 (1973).CrossRefGoogle Scholar
  30. Garattini, S.; Marcucci, F.; Morselli, P.L. and Mussini, E.: The significance of measuring blood levels of benzodiazepines; in Davies and Prichard (Eds) Biological Effects of Drugs in Relation to their Plasma Concentrations, pp. 211–225 (MacMillan, London 1973b).Google Scholar
  31. Garattini, S.; Marcucci, F. and Mussini E.: Biotransformation of drugs to pharmacologically active metabolites; in Eichler, Farah, Herken and Welch (Eds) Handbook of Experimental Pharmacology, Vol. 28, pp. 113–119 (Springer-Verlag, New York, 1975).Google Scholar
  32. Garattini, S.; Mussini, E. and Randall, L.O. (Eds): The Benzodiazepines (Raven Press, New York, 1973a).Google Scholar
  33. Ghoneim, M.M. and Korttila, K.: Pharmacokinetics of intravenous anaesthetics: Implications for clinical use. Clinical Pharmacokinetics 2: 344–372 (1977).PubMedCrossRefGoogle Scholar
  34. Greenblatt, D.J. and Koch-Weser, J.: Clinical toxicity of chlordiazepoxide and diazepam in relation to serum albumin concentration: A report from the Boston Collaborative Drug Surveillance Program. European Journal of Clinical Pharmacology 7: 259–262 (1974).PubMedCrossRefGoogle Scholar
  35. Greenblatt, D.J. and Shader, R.I.: Benzodiazepines, pt. I and pt. II. New England Journal of Medicine 291: 1011–1015, 1239-1243 (1974).PubMedCrossRefGoogle Scholar
  36. Hayer, S.L.; Pablo, G.; Radomsky, T. and Palmer, R.F.: Ethanol and Oral diazepam absorption. New England Journal of Medicine 296: 186–189 (1977).CrossRefGoogle Scholar
  37. Hendel, J.: Cumulation in cerebrospinal fluid of the N-desmethyl metabolite after long-term treatment with diazepam in man. Acta Pharmacologica et Toxicologica 37: 17–22 (1975).PubMedCrossRefGoogle Scholar
  38. Hillestad, L.; Hansen, T.; Melsom, H. and Drivenes, A.: Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration. Clinical Pharmacology and Therapeutics 16: 479–484 (1974a).PubMedGoogle Scholar
  39. Hillestad, L.; Hansen, T. and Melsom, H.: Diazepam metabolism in normal man. II. Serum concentration and clinical effect after oral administration and cumulation. Clinical Pharmacology and Therapeutics 16: 485–489 (1974b).PubMedGoogle Scholar
  40. Hvidberg, E.F. and Dam, M.: Clinical pharmacokinetics of anticonvulsants. Clinical Pharmacokinetics 1: 161–188 (1976).PubMedCrossRefGoogle Scholar
  41. Idanpaan-Heikkila, J.E.; Jouppila, P.I.; Puolakka, JO. and Vorne, M.S.: Placental transfer and fetal metabolism of diazepam in early human pregnancy. American Journal of Obstetrics and Gynecology 109: 1011–1016 (1971).PubMedGoogle Scholar
  42. Kangas, L.; Kanto, J.; Forsstrom, J. and Iisalo, E.: Protein binding of diazepam and N-demethyldiazepam in patients with poor renal function. Clinical Nephrology 5: 114–118 (1976).PubMedGoogle Scholar
  43. Kanto, J. and Erkkola, R.: The feto-maternal distribution of diazepam in early human pregnancy. Annales Chirurgiae et Gynaecologiae Fenniae 63: 489–491 (1974).PubMedGoogle Scholar
  44. Kanto, J.; Erkkola, R. and Sellman, R.: Distribution and metabolism of diazepam in early and late human pregnancy. Postnatal metabolism of diazepam. Acta Pharmacologica et Toxicologica 35:Suppl. 36 (1974a).Google Scholar
  45. Kanto, J.; Erkkola, R. and Sellman, R.: Perinatal metabolism of diazepam. British Medical Journal 1: 641–642 (1974b).PubMedCrossRefGoogle Scholar
  46. Kanto, J.; Iisalo, E.; Lehtinen, V. and Salminen, J.: The concentrations of diazepam and its metabolites in the plasma after an acute and chronic administration. Psychopharmacologia 36: 123–131 (1974c).PubMedCrossRefGoogle Scholar
  47. Kanto, J.; Kangas, L. and Siirtola, T.: Cerebrospinal-fluid concentrations of diazepam and its metabolites in man. Acta Pharmacologica et Toxicologica 36: 328–334 (1975).PubMedCrossRefGoogle Scholar
  48. Kaplan, S.A.; Jack, M.L.; Alexander, K. and Weinfeld, R.E.: Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. Journal of Pharmaceutical Sciences 62: 1789–1796 (1973).PubMedCrossRefGoogle Scholar
  49. Kesson, CM.; Gray, J.M.B. and Lawson, D.H.: Benzodiazepine drugs in general medical patients. British Medical Journal 1: 680–682 (1976).PubMedCrossRefGoogle Scholar
  50. Klotz, U; Antonin, K.-H. and Bieck, P.R.: Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig, and rat. Journal of Pharmacology and Experimental Therapeutics 199: 67–73 (1976a).PubMedGoogle Scholar
  51. Klotz, U.; Antonin, K.L. and Bieck, P.R.: Comparison of the pharmacokinetics of diazepam after single and subchronic doses. European Journal of Clinical Pharmacology 10: 121–126 (1976b).PubMedCrossRefGoogle Scholar
  52. Klotz, U.; Avant, G.R.; Hoyumpa, A.; Schenker, S. and Wilkinson, G.R.: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. Journal of Clinical Investigation 55: 347–359 (1975).PubMedCrossRefGoogle Scholar
  53. Korttila, K. and Kangas, L.: Unchanged protein binding and the increase of serum diazepam levels after food intake. Acta Pharmacologica et Toxicologica 40: 241–246 (1977).PubMedCrossRefGoogle Scholar
  54. Krasner, J. and Yaffe, S.J.: Drug-protein binding in the neonate; in Morselli, Garattini and Sereni (Eds) Basic and Therapeutic Aspects of Perinatal Pharmacology, pp.357–366 (Raven Press, New York 1975).Google Scholar
  55. Kvetina, J.; Marcucci, F. and Fanelli, R.: Metabolism of diazepam in isolated perfused liver of rat and mouse. Journal of Pharmacy and Pharmacology 20: 807–808 (1968).PubMedCrossRefGoogle Scholar
  56. Lasagna, L.: The role of benzodiazepines in nonpsychiatric medical practice. American Journal of Psychiatry 134: 656–658 (1977).PubMedGoogle Scholar
  57. Linnoila, M.; Korttila, K. and Mattila, M.J.: Effect of food and repeated injections on serum diazepam levels. Acta Pharmacologica et Toxicologica 36: 181–186 (1975).PubMedCrossRefGoogle Scholar
  58. Linnoila, M. and Mattila, M.J.: Drug interaction on psychomotor skills related to driving: Diazepam and alcohol. European Journal of Clinical Pharmacology 5: 186–194 (1973).CrossRefGoogle Scholar
  59. Linnoila, M.; Saario, I. and Maki, M.: Effect of treatment with diazepam or lithium and alcohol on psychomotor skills related to driving. European Journal of Clinical Pharmacology 7: 337–342 (1974).PubMedCrossRefGoogle Scholar
  60. Mahon, W.A.; Inaba, T.; Umeda, T.; Tsutsumi, E. and Stone, R.; Biliary elimination of diazepam in man. Clinical Pharmacology and Therapeutics 19: 443–450 (1976).PubMedGoogle Scholar
  61. Mandelli, M.; Morselli, P.L.; Nordio, S.; Pardi, G.; Principi, N.; Sereni, F. and Tognoni, G.: Placental transfer of diazepam and its disposition in the newborn. Clinical Pharmacology and Therapeutics 17: 564–572 (1975).PubMedGoogle Scholar
  62. Marcucci, F.; Fanelli, R.; Frova, M. and Morselli, P.L.: Levels of diazepam in adipose tissue of rats, mice and man. European Journal of Pharmacology 4: 464–466 (1968b).PubMedCrossRefGoogle Scholar
  63. Marcucci, F.; Fanelli, R. and Mussini, E.: A method for gas Chromatographie determination of benzodiazepines. Journal of Chromatography 37: 318–320 (1968a).PubMedCrossRefGoogle Scholar
  64. Marcucci, F.; Fanelli, R.; Mussini, E. and Garattini, S.: Further studies on species difference in diazepam metabolism. European Journal of Pharmacology 9: 253–256 (1970).PubMedCrossRefGoogle Scholar
  65. Marcucci, F.; Guaitani, A.; Kvetina, J.; Mussini, E. and Garattini, S.: Species difference in diazepam metabolism and anticonvulsant effect. European Journal of Pharmacology 4: 467–470 (1968c).PubMedCrossRefGoogle Scholar
  66. Morselli, P.L.: Clinical pharmacokinetics in neonates. Clinical Pharmacokinetics 1: 81–98 (1976).PubMedCrossRefGoogle Scholar
  67. Morselli, P.L.; Cassano, G.B.; Placidi, G.F.; Muscettola, G.B. and Rizzo, M.: Kinetics of the distribution of 14C-diazepam and its metabolites in various areas of cat brain; in Garattini, Mussini and Randall (Eds) The Benzodiazepines, pp.129–143 (Raven Press, New York, 1973a).Google Scholar
  68. Morselli, P.L.; Mandelli, M.; Tognoni, G.; Principi, N.; Pardi, G. and Sereni, F.: Drug interactions in the human fetus and in the newborn infant; in Morselli, Garattini and Cohen (Eds) Drug Interactions, pp.259–270 (Raven Press, New York, 1974).Google Scholar
  69. Morselli, P.L.; Principi, N.; Tognoni, G.; Reali, E.; Belvedere, G.; Standen, S.M. and Sereni, F.: Diazepam elimination in premature and full term infants, and children. Journal of Perinatal Medicine 1: 133–141 (1973b).PubMedCrossRefGoogle Scholar
  70. Nicholson, A.N. and Stone, B.M.: Effect of a metabolite of diazepam, 3-hydroxydiazepam (Temozepam), on sleep in man. British Journal of Clinical Pharmacology 3: 543–550 (1976).PubMedCrossRefGoogle Scholar
  71. Orme, M.; Breckenridge, A. and Brooks, R.V.: interactions of benzodiazepines with warfarin. British Medical Journal 3: 611–614 (1972).PubMedCrossRefGoogle Scholar
  72. Patrick, M.J.; Tilstone, W.J. and Reavey, P.: Diazepam and breast-feeding. Lancet 1: 542–543 (1972).PubMedCrossRefGoogle Scholar
  73. Sagen, N. and Haram, K.: Diazepam (Valium) as an anaesthetic for operative vaginal delivery. Acta Obstetricia et Gynecologica Scandinavica 52: 153–156 (1973).PubMedCrossRefGoogle Scholar
  74. Scher, J.; Hailey, D.M. and Beard, R.W.: The effects of diazepam on the fetus. Journal of Obstetrics and Gynaecology of the British Commonwealth 79: 635–638 (1972).PubMedCrossRefGoogle Scholar
  75. Schiff, D.; Chang, G. and Stern, L.: Fixed drug combinations and the displacement of bilirubin from albumin. Pediatrics 48: 139–141 (1971).PubMedGoogle Scholar
  76. Schwartz, D.E.; Vecchi, M.; Ronco, A. and Kaiser, K.: Blood levels after administration of 7-chloro-1,3-dihydro-l-methyl-5-phenyl-2H-l, 4-benzodiazepine-2-one (diazepam) in various forms. Arzneimittel-Forschung 16: 1109–1110 (1966).PubMedGoogle Scholar
  77. Schwartz, M.A.; Koechlin, B.A.; Postma, E.; Palmer, S. and Krol, G.: Metabolism of diazepam in rat, dog and man. Journal of Pharmacology and Experimental Therapeutics 149: 423–435 (1965).PubMedGoogle Scholar
  78. Sellman, R.; Kanto, J. and Pekkarinen, J.: Biliary excretion of diazepam and its metabolites in man. Acta Pharmacologica et Toxicologica 37: 242–249 (1975b).PubMedCrossRefGoogle Scholar
  79. Sellman, R.: Pekkarinen, A.; Kangas, L. and Raijola, E.: Reduced concentrations of plasma diazepam in chronic alcoholic patients following an oral administration of diazepam. Acta Pharmacologica et Toxicologica 36: 25–32 (1975a).PubMedCrossRefGoogle Scholar
  80. Sereni, F.; Mandelli, M.; Principi, N.; Tognoni, G.; Pardi, G. and Morselli, P.L.: Induction of drug metabolizing enzyme activities in the human fetus and in the newborn infant; in Frey, Knox and Greengard (Eds) Enzyme, pp.318–329 (Karger, Basel, 1973).Google Scholar
  81. Shader, R.I. and Greenblatt, D.J.: Clinical implications of benzodiazepine pharmacokinetics. American Journal of Psychiatry 134: 652–656 (1977).PubMedGoogle Scholar
  82. Shannon, R.W.; Fraser, G.P.; Aitken, R.G. and Harper J.R.: Diazepam in preeclamptic toxaemia with special reference to its effect on the newborn infant. British Journal of Clinical Practice 26: 271–275 (1972).PubMedGoogle Scholar
  83. Tansella, M.; Siciliani, O.; Burti, L.; Schiavon, M.; Zimmermann Tanzella, C.H.; Gema, M.; Tognoni, G. and Morselli, P.L.: N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologica 41: 81–85 (1975).CrossRefGoogle Scholar
  84. Tansella, M.; Zimmermann, C.H.; Tansella, L.; Ferrario, L.; Preziati, L.; Tognom, G. and Lader, M.: Plasma concentrations of diazepam, nordiazepam and amylobarbitone after short-term treatment in anxious patients. Pharmakopsychiatrie. In press (1978).Google Scholar
  85. Thiessen, J.J.; Sellers, E.M.; Denbeigh, P. and Dolman, L.: Plasma protein binding of diazepam and tolbutamide in chronic alcoholics. Journal of Clinical Pharmacology 16: 345–351 (1976).PubMedGoogle Scholar
  86. Tognoni, G.; Gomeni, R.; De Maio, D.; Alberti, G.G.; Franciosi, P. and Scieghi, G.: Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. British Journal of Clinical Pharmacology 2: 227–232 (1975).PubMedCrossRefGoogle Scholar
  87. Tsutsumi E.; Inaba, T.; Mahon, W.A. and Kalow, W.: The displacing effect of a fatty acid on the binding of diazepam to human serum albumin. Biochemical Pharmacology 24: 1361–1362 (1975).PubMedCrossRefGoogle Scholar
  88. Tyrer, P.: The benzodiazepine bonanza. Lancet 2: 709–710 (1974).PubMedCrossRefGoogle Scholar
  89. Van Der Kleijn, E.; Van Rossum, J.M.; Muskens, E.T.J.M. and Rijntjes, N.V.M.: Pharmacokinetics of diazepam in dogs, mice and humans. Acta Pharmacologica et Toxicologica 29 (Suppl. 3): 109–127 (1971).Google Scholar
  90. Zingales, I.A.: Diazepam metabolism during chronic medication. Unbound fraction in plasma, erythrocytes and urine. Journal of Chromatography 75: 55–78 (1973).PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press 1978

Authors and Affiliations

  • Marinella Mandelli
    • 1
  • Gianni Tognoni
    • 1
  • Silvio Garattini
    • 1
  1. 1.Istituto di Ricerche Farmacologiche ‘Mario Negri’MilanItaly

Personalised recommendations